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Abstract
The histamine I receptor antagonist diphenhydramine is a freely available, over the counter
medication for sleep and the most frequently used antihistamine drug. It inhibits the fast
sodium channels and, at higher concentrations, the repolarising potassium channels, particu-
larly Ikr which leads to prolongation of the action potential and the QT interval. The toxicity of
diphenhydramine is dose-dependent, with a critical dose limit of 1.0 g. We report a case of a young
woman who consumed more than 3 g of diphenhydramine in the setting of alcohol intoxication
and developed QTc prolongation with nonsustained polymorphic ventricular tachycardia. These
changes reverted to normal with supportive treatment. An overdose of diphenhydramine with
concomitant alcohol use can induce torsade de pointes in an otherwise normal heart. (Cardiol J
2010; 17, 5: 509–511)
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Introduction
Antihistamines are among the most frequent-
ly prescribed drugs worldwide. Because of their
excellent safety record, most can be obtained with-
out prescription. They are common ingredients in
non-prescription anti-allergy products and also in
sleep aids. Diphenhydramine is an H-1 antihista-
mine of the ethanolamine type with anticholinergic
and local anaesthetic properties [1]. It is a freely
available, over the counter medication. Most cases
of diphenhydramine overdose present with anti-
cholinergic, neurological and cardiovascular symp-
toms. Among the cardiovascular manifestations,
arrhythmic complications and conduction abnorma-
lities presenting as wide QRS complex, bundle
branch block and prolonged QT interval are seen
on the electrocardiogram [2, 3]. We present a case
with QT interval prolongation and nonsustained poly-
morphic ventricular tachycardia with diphenhy-
dramine overdose.
Case presentation
A 44 year-old female was found unresponsive
in her apartment with an almost empty bottle of
diphenhydramine. The bottle was supposed to con-
tain 100 tablets of diphenhydramine 50 mg (Night-
time Sleep Aid — CVS Pharmacy) but had only
40 tablets remaining. She was immediately brought to
the emergency room, where after a few hours, she
recovered enough to state that she had ingested
60 tablets of diphenhydramine along with alcohol as
a suicidal gesture. She also complained of palpita-
tions and chest pain. The troponins were minimal-
ly elevated. The electrogardiogram showed marked
QTc interval prolongation at 786 ms (Fig. 1) with
nonsustained polymorphic ventricular tachycardia
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(Fig. 2). Her potassium and magnesium levels were
normal. Her blood alcohol level was 0.21%. She was
not on any other QT interval prolonging medica-
tions. Echocardiography revealed a structurally
normal heart and cardiac catheterization showed
normal coronaries. Serial electrocardiograms
showed a gradual resolution of the QT interval pro-
longation and the T wave abnormality. By Day 5,
the QT interval had become normal (400 ms) and
T wave abnormalities had resolved (Fig. 3). No fur-
ther arrhythmias were noted and her hospital
course remained uneventful. Psychiatry consulta-
tion was obtained and the patient was later dis-
charged home with a psychiatry follow-up.
Discussion
The older antihistamines are known for their
anticholinergic and sedative effects. Some of them
have the same potential for causing arrhythmias as
the newer non-sedative antihistamines. To date,
most research in this area has been directed at stud-
ying the newer non-sedating antihistamines. Al-
though an overdose of older antihistamines has fre-
quently been reported, less is known about their
cardiac effects. The manufacturer’s labeling for one
of the oldest agents, diphenhydramine, lists “pal-
pitations, tachycardia and extrasystoles” as poten-
tial adverse effects [4]. A suggestion that diphen-
hydramine could cause torsade de pointes (TdP)
was found during an analysis of computerized pre-
scription records reported by Pratt et al. [5]. They
compared the risk of occurrence of life-threatening
ventricular arrhythmias with terfenadine with that
for non-prescription antihistamines. The authors
described two cases of TdP associated with diphen-
hydramine and could not detect any difference in
the risk of life-threatening arrhythmias between
Figure 1. QT prolongation to 786 ms.
Figure 2. Torsade de pointes.
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terfenadine and non-prescription antihistamines,
mainly diphenhydramine. This raises the question
of whether diphenhydramine, one of the most com-
monly used drugs in the world, may also be able to
induce TdP.
TdP is a syndrome of polymorphic ventricular
tachycardia that occurs in the setting of marked
prolongation of the QT interval on the surface elec-
trocardiogram. It occurs due to the slowing of re-
polarization due to the block of the delayed rectifi-
er potassium current (Ikr) that leads to action po-
tential duration prolongation. This slowing of
repolarization consistently precedes and is asso-
ciated with activation of a depolarizing current. The
resultant bradycardia tends to predispose to TdP.
Diphenhydramine toxicity is dose-dependent.
At higher concentrations, it inhibits the potassium
channels, resulting in QT interval prolongation and
abnormal ventricular repolarization. A retrospective
analysis of 126 patients with diphenhydramine over-
dose (the majority of cases involving a dose > 500 mg),
revealed a corrected QT interval (453 ± 43 ms)
significantly longer in diphenhydramine overdose
patients than that in control subjects (416 ± 35 ms)
[6]. Interestingly, none of the patients reported in
this study experienced torsade.
Our patient took 3 g of diphenhydramine, and
along with alcohol ingestion, developed torsade de
pointes with markedly abnormal T waves. TdP is
rare with diphenhydramine overdose, possibly be-
cause of the ‘protective’ effect of the associated
tachycardia caused by the anticholinergic and hypo-
tensive effects of diphenhydramine.
This case of torsade is, to our knowledge, only
the third reported case in English literature of
diphenhydramine toxicity.
Acknowledgements
The authors do not report any conflict of inte-
rest regarding this work.
References
1. Cirillo VJ, Tempero KF. Pharmacology and therapeutic use of
antihistamines. Am J Hosp Pharm, 1977; 33: 1200–1207.
2. Hestand HE, Teske DW. Diphenhydramine hydrochloride in-
toxication. J Pediatr, 1977; 90: 1017–1018.
3. Mary F, Michael H, John T. Response of life threatening dimen-
hydrinate intoxication to sodium bicarbonate administration. Clin
Toxicol, 1991; 29: 527–535.
4. Woosley RL ed. Diphenhydramine. In: Physician’s desk refe-
rence. Med Econ Data, Montvale, NJ 1994: 1719–1720.
5. Pratt CM, Hertz RP, Ellis BE et al. Risk of developing life threat-
ening ventricular arrhythmia associated with terfenadine in com-
parison with over the counter antihistamines, ibuprofen and ele-
mastine. Am J Cardiol, 1994; 73: 346–352.
6. Zareba W, Moss AJ, Rosero SZ et al. Electrocardiographic find-
ings in patients with diphenhydramine overdose. Am J Cardiol,
1997; 80: 1168–1173.
Figure 3. Reversal of QT prolongation with T wave inversion.
